1) The TME induced viability, proliferation, and alterations in the expression of biomarkers related to EMT (elevated vimentin, depressed E-cadherin), leading to higher motility and invasiveness in CRC cells. The gene discussed is CDH1; the disease is colorectal carcinoma.